Increase in AR mRNA and protein is both necessary and sufficient to convert prostate cancer growth from a hormone-sensitive to a hormone-refractory stage, and is dependent on a functional ligand-binding domain [16,17]. This evidence concerns the gene AR and prostate carcinoma.